POPULATION SCIENCES PROGRAM
POPULATION SCIENCES PROGRAM
批准号:
7944537
负责人:
FRANK L. MEYSKENS
金额:
$2.04万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-06 至 2012-01-31
关键词:
AffectArginineBehavioralCancer Center Support GrantCancer ControlCancer EtiologyCessation of lifeChemopreventionChemopreventive AgentClinicalColorectal AdenomaColorectal CancerContinuance of lifeDL-alpha-DifluoromethylornithineDataDietDiseaseErlotinibFundingFutureGeneticGoalsHeadHereditary Breast and Ovarian Cancer SyndromeHispanicsIncidenceIndividualKnowledgeLife StyleMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of cervix uteriMalignant neoplasm of pancreasMeasuresMetastatic toMethodologyModificationMolecular GeneticsMorbidity - disease rateOrganOutcomeParticipantPatientsPeer ReviewPharmacogeneticsPhasePhase III Clinical TrialsPilot ProjectsPopulationPopulation HeterogeneityPopulation SciencesPredispositionPremalignantPreventionProcessPublicationsPublishingQuality of CareQuality of lifeRandomizedRecurrenceResearchRiskSchoolsSecondary PreventionSerologicalSiteSulindacTestingTherapeuticTranslatingTranslationsUniversity of California Irvine Cancer CenterWomanadenomacancer preventioncancer riskcancer sitedesignepidemiology studyfollow-upgenetic epidemiologygenetic risk factorhealth disparityhigh risklifestyle factorsmalignant breast neoplasmmembermortalityoutreachoutreach programpreventprogramspsychosocialsurvivorshiptumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Population Sciences Research Program (led by H. Anton-Culver and S. Neuhausen) is composed of
three themes, Genetic Epidemiology (headed by S. Neuhausen), Prevention (headed by S. Lipkin), and
Outreach and Cancer Control (headed by L. Wenzel). The Program is focused on investigating the
continuum of cancer from normal to pre-malignant to malignant to metastatic disease. There are interactions
and interplay among the three themes within cancer sites and across the continuum. The main objectives of
the research are to build on current knowledge and to create new paradigms to understand: a) how cancers
develop in susceptible populations; b) how to prevent cancer from developing; c) how cancers progress; and
d) how to reduce morbidity and mortality from cancer. This research program is focused on organ-specific
sites. Methodologies and approaches that are developed in one cancer are translated into other cancers. In
the Genetic Epidemiology theme, breast cancer is a primary focus. There are five on-going studies to
investigate genetic and lifestyle factors associated with risk of breast cancer. The identification of lifestyle
and genetic factors that contribute to breast cancer risk is crucial to design both preventative and therapeutic
strategies and to identify at risk individuals, in order to reduce the incidence of and death from this disease.
In the Prevention theme, the focus is on chemoprevention. One of the most successful chemoprevention
trials for secondary prevention of colorectal cancer is the randomized phase III study of Sulindac plus
Difluoromethylornithine (DFMO) in Reducing Recurrent Colorectal Adenomas. Overall a highly significant
reduction of 70% of all adenomas was achieved in those receiving DFMO/Sulindac (P<0.001). Advanced
adenomas were reduced by 90% (P=0.001). In the Outreach and Cancer Control theme, a major focus is
cervical cancer disease processes at the phase between susceptibility and pre-malignancy and after
suspicion of a pre-malignancy in a high risk group of Hispanic women. Factors that influence survivorship
after the malignancy has been treated are being identified to aid in cancer control and potentially prevent
metastatic disease. Future emphases of the Population Sciences Program include quantitative assessment
of factors that affect cancer etiology, progression and outcome to generate clues for cancer prevention
targets. We will continue to focus on health disparities as they modify risk and outcome of cancer.
The PS Program has 13 Members, representing four Departments and two Schools, and has $3,031,090 in
direct cancer-related peer-reviewed funding, 11 projects of which are funded by NCI for a direct total of
$2,382,560. In 2007, Members published a total of 60 publications with 45 of those being cancer-related of
which 36% were inter- and 33% were intra-related.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The 19th Annual Meeting of the Pan American Society for Pigment Cell Research Conference
-
批准号:8986392
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2015
-
负责人:FRANK L. MEYSKENS
-
依托单位:
7th International Conference on Clinical Cancer Prevention 2012 with Consensus Co
-
批准号:8400378
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2013
-
负责人:FRANK L. MEYSKENS
-
依托单位:
PROTOCOL SPECIFIC RESEARCH SUPPORT
-
批准号:7944582
-
项目类别:
-
资助金额:$4.78万
-
财政年份:2009
-
负责人:FRANK L. MEYSKENS
-
依托单位:
DEVELOPMENT FUNDS
-
批准号:7944501
-
项目类别:
-
资助金额:$25.5万
-
财政年份:2009
-
负责人:FRANK L. MEYSKENS
-
依托单位:
STRUCTURAL MOLECULAR BIOLOGY PROGRAM
-
批准号:7944517
-
项目类别:
-
资助金额:$1.49万
-
财政年份:2009
-
负责人:FRANK L. MEYSKENS
-
依托单位:
SENIOR LEADERSHIP
-
批准号:7944489
-
项目类别:
-
资助金额:$11.86万
-
财政年份:2009
-
负责人:FRANK L. MEYSKENS
-
依托单位:
STAFF INVESTIGATORS
-
批准号:7944497
-
项目类别:
-
资助金额:$3.44万
-
财政年份:2009
-
负责人:FRANK L. MEYSKENS
-
依托单位:
University of California, Irvine Cancer Center Support Grant
-
批准号:7929965
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2009
-
负责人:FRANK L. MEYSKENS
-
依托单位:
CANCER CENTER ADMINISTRATION
-
批准号:7944504
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2009
-
负责人:FRANK L. MEYSKENS
-
依托单位:
PROTOCOL REVIEW MONITORING SYSTEM
-
批准号:7944577
-
项目类别:
-
资助金额:$4.63万
-
财政年份:2009
-
负责人:FRANK L. MEYSKENS
-
依托单位:
CARCINOGENESIS PROGRAM
-
批准号:7944508
-
项目类别:
-
资助金额:$1.79万
-
财政年份:2009
-
负责人:FRANK L. MEYSKENS
-
依托单位:
University of California, Irvine Cancer Center Support Grant
-
批准号:7931723
-
项目类别:
-
资助金额:$150.72万
-
财政年份:2009
-
负责人:FRANK L. MEYSKENS
-
依托单位:
PROGRAM PLANNING AND EVALUATION
-
批准号:7944499
-
项目类别:
-
资助金额:$4.9万
-
财政年份:2009
-
负责人:FRANK L. MEYSKENS
-
依托单位:
PanAmerican Society for Pigment Cell Research (PASPCR)
-
批准号:6836156
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2004
-
负责人:FRANK L. MEYSKENS
-
依托单位:
PHASE I AND II CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
-
批准号:7543342
-
项目类别:
-
资助金额:$157.7万
-
财政年份:2003
-
负责人:FRANK L. MEYSKENS
-
依托单位:--
Phase III Colon Cancer Prevention Trial
-
批准号:6937216
-
项目类别:
-
资助金额:$70.61万
-
财政年份:2002
-
负责人:FRANK L. MEYSKENS
-
依托单位:
Phase III Colon Cancer Prevention Trial
-
批准号:6666738
-
项目类别:
-
资助金额:$88.27万
-
财政年份:2002
-
负责人:FRANK L. MEYSKENS
-
依托单位:
Phase III Colon Cancer Prevention Trial
-
批准号:6789437
-
项目类别:
-
资助金额:$79.73万
-
财政年份:2002
-
负责人:FRANK L. MEYSKENS
-
依托单位:
Phase III Colon Cancer Prevention Trial
-
批准号:7111701
-
项目类别:
-
资助金额:$76.86万
-
财政年份:2002
-
负责人:FRANK L. MEYSKENS
-
依托单位:
Phase III Colon Cancer Prevention Trial
-
批准号:6543079
-
项目类别:
-
资助金额:$106.56万
-
财政年份:2002
-
负责人:FRANK L. MEYSKENS
-
依托单位:
国内基金
海外基金
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位: